CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...
In the fractionating columns in use today, losses occur when intermediate products flow from one column to the next: the separated fluids tend to mix again before the process continues to separate ...
Two procedures for fractionating enzyme preparations on a column, somewhat different from the previously described chromatopile 1, have been found useful in preliminary tests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback